SG50831A1 - Fluorinated bitamin d3 analogs - Google Patents

Fluorinated bitamin d3 analogs

Info

Publication number
SG50831A1
SG50831A1 SG1997001491A SG1997001491A SG50831A1 SG 50831 A1 SG50831 A1 SG 50831A1 SG 1997001491 A SG1997001491 A SG 1997001491A SG 1997001491 A SG1997001491 A SG 1997001491A SG 50831 A1 SG50831 A1 SG 50831A1
Authority
SG
Singapore
Prior art keywords
bitamin
fluorinated
analogs
fluorinated bitamin
Prior art date
Application number
SG1997001491A
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG50831A1 publication Critical patent/SG50831A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1997001491A 1996-05-23 1997-05-12 Fluorinated bitamin d3 analogs SG50831A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (1)

Publication Number Publication Date
SG50831A1 true SG50831A1 (en) 1998-07-20

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1997001491A SG50831A1 (en) 1996-05-23 1997-05-12 Fluorinated bitamin d3 analogs

Country Status (30)

Country Link
US (1) US5888994A (tr)
EP (1) EP0808831B1 (tr)
JP (1) JP2858571B2 (tr)
KR (1) KR100237523B1 (tr)
CN (1) CN1081184C (tr)
AR (1) AR007240A1 (tr)
AT (1) ATE195514T1 (tr)
AU (1) AU720098B2 (tr)
BR (1) BR9703373A (tr)
CA (1) CA2204478C (tr)
CO (1) CO4840512A1 (tr)
CZ (1) CZ157997A3 (tr)
DE (1) DE69702812T2 (tr)
DK (1) DK0808831T3 (tr)
ES (1) ES2150719T3 (tr)
GR (1) GR3034832T3 (tr)
HR (1) HRP970274A2 (tr)
HU (1) HUP9700927A3 (tr)
IL (1) IL120842A0 (tr)
MA (1) MA24345A1 (tr)
NO (1) NO971934L (tr)
NZ (1) NZ314838A (tr)
PL (1) PL320131A1 (tr)
PT (1) PT808831E (tr)
SG (1) SG50831A1 (tr)
TR (1) TR199700418A2 (tr)
TW (1) TW374762B (tr)
UY (1) UY24563A1 (tr)
YU (1) YU19997A (tr)
ZA (1) ZA974334B (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
EP0981514B1 (en) * 1997-05-16 2006-04-05 Woman & Infants Hospital 3-epi vitamin d2 compounds and uses thereof
EP0981523B1 (en) * 1997-05-16 2005-12-07 Woman & Infants Hospital Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof
DE69814109T2 (de) * 1997-09-08 2004-02-26 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
ES2904546T3 (es) 2006-02-03 2022-04-05 Opko Renal Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
PL2679228T3 (pl) 2006-06-21 2018-07-31 Opko Ireland Global Holdings, Ltd. Terapia z użyciem środka do uzupełniania witaminy D i środka do zastępowania hormonami witaminy D
CA2683628C (en) 2007-04-25 2018-03-06 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
DK2481400T3 (da) 2007-04-25 2014-09-29 Opko Ip Holdings Ii Inc Orale præparater med kontrolleret frigivelse omfattende en vitamin D-forbindelse og en voksagtig bærer
LT2552484T (lt) 2010-03-29 2020-04-27 Opko Ireland Global Holdings, Ltd. Būdai ir kompozicijos, skirti paratiroidų lygiams sumažinti
US8754067B2 (en) 2010-11-12 2014-06-17 Wisconsin Alumni Research Foundation 22-haloacetoxy-homopregnacalciferol analogs and their uses
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
EP3193925A2 (en) 2014-08-07 2017-07-26 OPKO Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin d
CN108883120A (zh) 2016-03-28 2018-11-23 欧普科爱尔兰环球控股有限公司 维生素d治疗方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
ATE141914T1 (de) * 1992-05-20 1996-09-15 Hoffmann La Roche Fluorierte analoge vitamins d3
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
TW267161B (tr) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
CO4840512A1 (es) 1999-09-27
NO971934L (no) 1997-11-24
US5888994A (en) 1999-03-30
NO971934D0 (no) 1997-04-25
ES2150719T3 (es) 2000-12-01
IL120842A0 (en) 1997-09-30
EP0808831A3 (en) 1999-02-03
DK0808831T3 (da) 2001-01-02
CA2204478A1 (en) 1997-11-23
TR199700418A3 (tr) 1997-12-21
UY24563A1 (es) 2000-12-29
MX9703776A (es) 1998-06-30
HRP970274A2 (en) 1998-04-30
DE69702812T2 (de) 2001-01-25
YU19997A (sh) 1999-07-28
CZ157997A3 (en) 1997-12-17
CN1081184C (zh) 2002-03-20
JPH1045712A (ja) 1998-02-17
AU2357297A (en) 1997-11-27
NZ314838A (en) 1998-01-26
ATE195514T1 (de) 2000-09-15
JP2858571B2 (ja) 1999-02-17
DE69702812D1 (de) 2000-09-21
AU720098B2 (en) 2000-05-25
PT808831E (pt) 2000-12-29
AR007240A1 (es) 1999-10-27
ZA974334B (en) 1997-11-24
KR100237523B1 (ko) 2000-01-15
CN1169425A (zh) 1998-01-07
EP0808831B1 (en) 2000-08-16
TW374762B (en) 1999-11-21
EP0808831A2 (en) 1997-11-26
KR970074763A (ko) 1997-12-10
MA24345A1 (fr) 1998-07-01
CA2204478C (en) 2006-11-21
GR3034832T3 (en) 2001-02-28
TR199700418A2 (tr) 1997-12-21
HU9700927D0 (en) 1997-07-28
HUP9700927A3 (en) 1999-07-28
BR9703373A (pt) 1998-09-15
HUP9700927A2 (hu) 1998-01-28
PL320131A1 (en) 1997-11-24

Similar Documents

Publication Publication Date Title
AP9701020A0 (en) Substituted indazole analogs
EP0888151A4 (en) MECHANICAL BRAKE FOR RECALL
IL117250A0 (en) Laryngoscope
HU9700926D0 (en) Vitamine d3 analogues
SG50831A1 (en) Fluorinated bitamin d3 analogs
EP0996458A4 (en) SANDRAMYCIN ANALOG
GB9414974D0 (en) Selectively fluorinated organic compounds
GB9602326D0 (en) Compounds
SG70010A1 (en) Fluorinated vitamin d3 analogs
GB2317360B (en) Handgrip
GB9601685D0 (en) Fluorinated compounds
ZA974332B (en) Fluorinated vitamin D3 analogs.
GB9500641D0 (en) Fluorinated compounds
IL120356A0 (en) Hydantocidin analogs
GB9415299D0 (en) Selectively fluorinated organic compounds
GB9616996D0 (en) Improved climbing aid
TW324902U (en) Handgrip structure
AU130690S (en) Cornice
GB9614341D0 (en) Cable
PL58225Y1 (en) Cable bushingh
PL55682Y1 (en) Cable point-holder
IL108662A0 (en) Stabilized platforms
TW360187U (en) Moist-throat structure for improvement type diving equipment
PL104562U1 (en) Sheath
GB9619750D0 (en) Respirator faceseal